EP0489853A1 - Interesterification des phospholipides - Google Patents

Interesterification des phospholipides

Info

Publication number
EP0489853A1
EP0489853A1 EP90914141A EP90914141A EP0489853A1 EP 0489853 A1 EP0489853 A1 EP 0489853A1 EP 90914141 A EP90914141 A EP 90914141A EP 90914141 A EP90914141 A EP 90914141A EP 0489853 A1 EP0489853 A1 EP 0489853A1
Authority
EP
European Patent Office
Prior art keywords
process according
lipase
fatty acid
phosphatidyl
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP90914141A
Other languages
German (de)
English (en)
Inventor
Kim Brint Pedersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of EP0489853A1 publication Critical patent/EP0489853A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6458—Glycerides by transesterification, e.g. interesterification, ester interchange, alcoholysis or acidolysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/091—Phenol resins; Amino resins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6481—Phosphoglycerides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Definitions

  • This invention relates to a process for exchanging acyl groups in a phospholipid by enzymatic ester exchange with a fatty acid ester or free fatty acid.
  • Phospholipids such as phosphatidyl choline, consist of glycerol esterified with 2 fatty acyl groups and one phosphate or esterified phosphate group.
  • phosphatidyl choline consist of glycerol esterified with 2 fatty acyl groups and one phosphate or esterified phosphate group.
  • JP-A 63-185,391 discloses a process whereby phospholipid and fatty acid (or ester) are treated with a suitable enzyme to obtain 10-20% exchange of fatty acid in 24-48 hours. Use of a carrier such as celite in the process is suggested.
  • the invention provides a process for exchanging acyl groups in a phospholipid by enzymatic ester exchange with a fatty acid ester or free fatty acid, characterized in that the enzyme is immobilized on a particulate macroporous carrier.
  • the enzyme used in the invention is immobilized on a particulate macroporous carrier.
  • the enzyme may be simply adsorbed on the carrier, or it may be attached to the carrier by cross-linking with glutaraldehyde or other cross- linking agent known in the art.
  • a preferred carrier type is weakly basic anion exchange resin, e.g. of acrylic, polystyrene or phenol-formaldehyde type.
  • weakly basic anion exchange resin e.g. of acrylic, polystyrene or phenol-formaldehyde type.
  • Examples of commercial products are Lewatit ® E 1999/85 (product of Bayer, West Germany) and Duolite ® ES-568 (Rohm & Haas).
  • Another preferred carrier type is an adsorbent (non-ionic) carrier, e.g. of the phenol-formaldehyde type, acrylic type or polypropylene type.
  • adsorbent non-ionic carrier
  • examples of commercial products are Lewatit E2001/85 (acrylic, product of Bayer) and Accurel EP-100 (polypropylene, product of AKZO).
  • Another preferred immobilization method uses an inorganic support material, and the enzyme is preferably attached to the support by adsorption or covalent coupling.
  • Such support materials and immobilization techniques are described in K. Mosbach (ed.): Methods in Enzymology, 44, "Immobilized Enzymes” (Academic Press, 1976).
  • a preferred inorganic support material is macroporous silica or silicate carriers e.g. macroporous silica carriers from Grace Chemicals described in Biocatalyst Supports SG BC 1E/June 1987 in which more than 90% of the particles have particle sizes between 100 and 1000 ⁇ m, wherein more than 80% of the pores in the particles exhibit a diameter between 5 and 45 times the diameter of the enzyme globules.
  • macroporous silica or silicate carriers e.g. macroporous silica carriers from Grace Chemicals described in Biocatalyst Supports SG BC 1E/June 1987 in which more than 90% of the particles have particle sizes between 100 and 1000 ⁇ m, wherein more than 80% of the pores in the particles exhibit a diameter between 5 and 45 times the diameter of the enzyme globules.
  • the immobilized enzymes useful for interesterification of phospholipids typically are loaded with 20,000 - 200,000 LU per g (dry weight) of catalyst (LU, Lipase Unit is defined in US 4,810,414).
  • the enzyme to be used may be a lipase of animal, plant or microbial origin.
  • a microbially produced lipase is preferred, e.g. a bacterial or fungal lipase.
  • suitable enzymes are lipases derived from the following organisms:
  • Rhizomucor also designated Mucor
  • R. miehei M. miehei
  • LipozymeTM Novo Nordisk a/s
  • Candida rugosa also termed C. cylindraceae, the lipase being available as Lipase OF (Meito Sangyo)).
  • the amount of water in the reaction system should be controlled, since a certain water activity is required to activate the immobilized enzyme, but too high water content may cause too much undesired hydrolysis of the phospholipid. It should be noted though, that the expected high value of a phospholipid containing a desired fatty acid may allow a high degree of hydrolysis during the interesterification process.
  • the amount of water in the reaction system should correspond to 5-15% of the dry weight of the immobilized lipase, or 0.05-1.5%, preferably 0.1-1.0% by weight of the total reaction system. Surprisingly, it was found that such a low water content is sufficient.
  • the immobilized enzyme may be hydrated before reaction, preferably to 5 - 15% water by weight.
  • water may be introduced by hydrating the catalyst as above, and further having some water dissolved in the substrate.
  • the interesterifying process should be carried out under conditions in which both the phospholipid and the fatty acid or fatty acyl ester are miscible in a fluid phase, e.g. solubilized in an organic solvent like hexane, heptane, petroleum ether or chlorinated hydrocarbons that also allows the enzyme catalyst to be active.
  • the phospholipid may be solubilized directly in the fatty acid or fatty acyl ester.
  • the process temperature should be chosen after considering thermostability of the immobilized enzyme. In many cases 20-60°C will be suitable. For very thermostable enzymes temperatures as high as 80°C may be used.
  • the process may be carried out as a batch reaction, where the ingredients are stirred gently throughout the reaction period. After the reaction the reaction products is separated from the immobilized enzyme simply by decanting or filtration.
  • the amount of immobilized enzyme in the reaction mixture will typically be 1 - 10% w/w, and the reaction time will generally be 0.5 - 72 hours, preferably 0.5 - 24 hours.
  • the process may be carried out continuously by letting the substrate mixture (and solvent, if used) pass through a fixed bed column of immobilized enzyme.
  • the residence time will typically be 1 - 12 hours.
  • the process of the invention may be applied to any desired kind of phospholipid containing fatty acyl ester groups.
  • phospholipid containing fatty acyl ester groups examples include phosphatidic acid, phosphatidyl choline, phosphatidyl serine, phosphatidyl glycerol, phosphatidyl inositol, phosphatidyl ethanolamine and diphosphatidyl glycerol.
  • Synthetic phospholipids with various hydroxy- compounds esterified to the phosphate group may also be processed. Acyl group to be incorporated
  • the process of the invention may be used to incorporate any desired fatty acid into phospholipid.
  • fatty acids that may be of particular interest are: - Long-chain (CJ3-C22) polyunsaturated fatty acid, such as linoleic, arachidonic, alpha-linolenic, eicosapentaenoic, docosahexaenoic or gamma- linolenic acids. These may be incorporated to improve the physiological or nutritional value of the phospholipid.
  • CgC 12 Medium-chain (CgC 12 ) or long chain (C- ⁇ C- j g) saturated fatty acids. These may be incorporated to modify emulsification properties, to modify the physiological value or to improve oxidation stability of the phospholipid.
  • the acyl groups to be incorporated into the phospholipid may be provided as free fatty acids or esters thereof.
  • the ester may particularly be a short-chain (C1-C3) alkyl ester, especially a methyl ester or ethyl ester.
  • the ester may be a triglyceride, especially a naturally occurring one.
  • Rhizomucor miehei lipase produced by cultivating a transformed Aspergillus oryzae was immobilized on Duolite ® ES-568 N.
  • the load was 99,200 LU per g (dry weight) of catalyst.
  • Humicola lanuginosa lipase produced by cultivating a transformed Aspergillus oryzae was immobilized on a macroporous silica carrier (Grace 6, product of Grace Chemicals). The load was 166,500 LU per g (dry weight) of catalyst.
  • Candida cylindracea lipase (Lipase-OF from Meito Sangyo) was immobilized on Accurel EP-100. The load was 34,200 LU per g (dry weight) of catalyst.
  • Epikuron 200 As phospholipid was used the commercial product Epikuron 200 from Lucas Meyer GmbH. This is a fractionated soybean lecithin containing min. 95% phosphatidyl choline, max. 4% lyso-phosphatidyl choline and a moisture and oil content of max. 3%. 5.5 g of Epikuron 200 was mixed with 12.0 g of decanoic acid and 90 ml of petroleum ether (b.p. 80-100°C). In this mixture the molar ratio of decanoic acid to phosphatidyl choline is approx. 10:1. Each of the immobilized R. miehei lipase and immobilized H.
  • lanuginosa lipase corresponding to a dry weight of 125 mg was weighed into a vial.
  • the lipases were humidified overnight at room temperature to a water content of 10% w/w for the R. miehei lipase and 11.3% w/w for the H. lanuginosa lipase.
  • 1.5 ml of the above mixture was added to the immobilized lipase.
  • gentle stirring was then carried out at 40°C for 24 hours. Then the substrate was separated from the enzyme catalyst.
  • the composition of fatty acids in the phosphatidyl choline was assayed as follows: Phosphatidyl choline was separated from fatty acids and lyso- phosphatidyl choline by thin layer chromatography on Silica gel 60 plates (Merck art. 5721) using CHCI 3 : CH3OH : H 2 0 (65 : 25 : 4, v/v/v) as solvent. After elution the plates were dried, and bands visualized by iodine vapors. The band corresponding to phosphatidyl choline was scraped off. The fatty acids esterified in the phosphatidyl choline in the scrape-off were methylated and the fatty acyl methyl esters were determined and quantitated by gas chromatography.
  • Phosphatidyl choline in the reference sample contained no decanoic acid.
  • Phosphatidyl choline treated with R. miehei lipase contained decanoic acid in an amount of 67% (w/w) of the total amount of fatty acids.
  • Phosphatidyl choline treated with H. lanuginosa lipase contained decanoic acid in an amount of 43% (w/w) of the total amount of fatty acids.
  • approx. half of the phosphatidyl choline in the reaction substrate had become hydrolyzed (estimated from the thin-layer chromatograms) during the reactions.
  • Example 1 As Example 1 but using 15.9 g myristic acid instead of 12.0 g lauric acid.
  • the molar ratio of myristic acid to phosphatidyl choline is approx. 10:1.
  • Phosphatidyl choline in the reference sample contained virtually no myristic acid (less than 0.5% (w/w)).
  • Phosphatidyl choline treated with R. miehei lipase or H. lanuginosa lipase contained myristic acid in an amount of 73% (w/w) and 56% (w/w), respectively, of the total amount of fatty acids.
  • Example 1 As in Example 1 approx. half of the phosphatidyl choline in the enzyme catalyzed experiments were estimated to have become hydrolyzed.
  • Phosphatidyl choline in the reference sample contained lauric acid in an amount of 1.6% (w/w) of the total amount of fatty acids.
  • Phosphatidyl choline treated with R. miehei, C. cylindracea, or H. lanuginosa lipases contained lauric acid in an amount of 51% (w/w), 30% (w/w), and 40% (w/w), respectively, of the total amounts of fatty acids.
  • Example 1 As in Example 1 approx. half of the phosphatidyl choline in the enzyme catalyzed experiments were estimated to have become hydrolyzed.
  • the molar ratio of alpha-linolenic acid to phosphatidyl choline is approx. 10:1.
  • the reaction was carried out under a blanket of argon.
  • Phosphatidyl choline in the reference sample and the R.miehei lipase treated sample contained C13.3 fatty acids in amounts of 7% (w/w) and 42% (w/w), respectively, of the total amount of fatty acids.
  • Phosphatidyl choline in the reference sample contained virtually no lauric acid.
  • Phosphatidyl choline treated with miehei or H. lanuginosa lipases contained lauric acid in an amount of 53% (w/w) and 43% (w/w), respectively, of the total amount of fatty acids.
  • a substrate containing 50 mg lauric acid and 10 mg phosphatidyl ethanolamine (grade 1, from Lipid Products) per ml petroleum ether (b.p. 80- 100°C) was made.
  • Immobilized R. miehei lipase corresponding to a dry weight of 125 mg was weighed into a vial.
  • the lipase was humidified overnight to a water content of 5% (w/w).
  • 1.5 ml of the above substrate was added to the lipase and stirred gently at 40°C for 12 hours.
  • Phosphatidyl ethanolamine in the reference sample contained virtually no lauric acid (less than 0.5% (w/w)).
  • Phosphatidyl ethanolamine treated with lipase contained lauric acid in an amount of 40% (w/w) of the total amount of fatty acids.
  • Phosphatidyl glycerol in the reference sample contained virtually no lauric acid (less than 0.5% (w/w)).
  • Phosphatidyl glycerol treated with lipase contained lauric acid in an amount of 22% (w/w) of the total amount of fatty acids.
  • lauric acid contained lauric acid in an amount of 22% (w/w) of the total amount of fatty acids.
  • enzyme treated reaction products only a low amount of lysophosphatidyl glycerol was apparent.
  • a new band of an unidentified compound had appeared. This compound may have been made by esterification of lauric acid to one of the free hydroxy groups in phosphatidyl glycerol.
  • the fatty acid composition of the unidentified compound was analyzed and found to contain 39% (w/w) lauric acid.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

Un procédé amélioré d'interestérification enzymatique d'un phospholipide avec un acide gras ou un ester est basé sur l'utilisation d'une enzyme immobilisée par l'adsorption sur un porteur macroporeux particulaire.
EP90914141A 1989-08-30 1990-08-29 Interesterification des phospholipides Withdrawn EP0489853A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK426089A DK426089D0 (da) 1989-08-30 1989-08-30 Omestring af phospholipider
DK4260/89 1989-08-30

Publications (1)

Publication Number Publication Date
EP0489853A1 true EP0489853A1 (fr) 1992-06-17

Family

ID=8131839

Family Applications (1)

Application Number Title Priority Date Filing Date
EP90914141A Withdrawn EP0489853A1 (fr) 1989-08-30 1990-08-29 Interesterification des phospholipides

Country Status (4)

Country Link
EP (1) EP0489853A1 (fr)
JP (1) JPH05501497A (fr)
DK (1) DK426089D0 (fr)
WO (1) WO1991003564A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5445955A (en) * 1992-05-25 1995-08-29 The Nisshin Oil Mills, Ltd. Immobilization of lipase on a polymer carrier containing epoxy and tertiary amino groups
US5989599A (en) * 1995-04-24 1999-11-23 Nestec S.A. Process for the interesterification of phospholipids
IL158553A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Method for preparing phosphatidylserine containing omega-3 acid moieties
WO2006054183A2 (fr) * 2004-11-17 2006-05-26 Natural Asa Phospholipides marins obtenus par synthese enzymatique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK402583D0 (da) * 1983-09-05 1983-09-05 Novo Industri As Fremgangsmade til fremstilling af et immobiliseret lipasepraeparat og anvendelse deraf
JPS63105686A (ja) * 1986-10-24 1988-05-10 Nippon Oil & Fats Co Ltd ホスフアチジルコリンのエステル交換方法
JP2630770B2 (ja) * 1987-01-27 1997-07-16 昭和産業株式会社 リン脂質の改質法
EP0320132B1 (fr) * 1987-12-09 1995-06-21 Kao Corporation Enzyme immobilisée et estérification et interestérification avec celle-ci

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9103564A1 *

Also Published As

Publication number Publication date
JPH05501497A (ja) 1993-03-25
DK426089D0 (da) 1989-08-30
WO1991003564A1 (fr) 1991-03-21

Similar Documents

Publication Publication Date Title
Kaewthong et al. Continuous production of monoacylglycerols by glycerolysis of palm olein with immobilized lipase
Mendes et al. Properties and biotechnological applications of porcine pancreatic lipase
EP0320132B1 (fr) Enzyme immobilisée et estérification et interestérification avec celle-ci
US5156963A (en) Immobilization of lipase by adsorption on a particulate macroporous resin
Bloomer et al. Triglyceride Interesterification by Lipases: 2. Reaction parameters for the reduction of trisaturated impurities and diglycerides in batch reactions
US6605452B1 (en) Fatty acid polyol ester-coated lipase complex immobilized on insoluble matrix
Ghamgui et al. Immobilization studies and biochemical properties of free and immobilized Rhizopus oryzae lipase onto CaCO3: A comparative study
US9068175B2 (en) Modified-immobilized enzymes of high tolerance to hydrophilic substrates in organic media
Mutua et al. Lipase-catalyzed modification of phospholipids: incorporation of n-3 fatty acids into biosurfactants
US5569594A (en) Transesterification with lipase immobilized on a polymer containing epoxy and tertiary amino groups
CA2368179A1 (fr) Complexe lipase-tensioactif immobilise sur une matrice insoluble
Briand et al. Enzymatic fatty esters synthesis in aqueous medium with lipase from Candida parapsilosis (Ashford) Langeron and Talice
EP0407959A2 (fr) Procédé de production de monoesters d'un polyol et d'un acide gras
Ghattas et al. Monoolein production by triglycerides hydrolysis using immobilized Rhizopus oryzae lipase
Mustranta et al. Transesterification of phospholipids in different reaction conditions
EP0489853A1 (fr) Interesterification des phospholipides
JPH01262795A (ja) 固定化酵素の製造方法
JPH0543354B2 (fr)
WO1991003565A1 (fr) Hydrolyse de phospholipides a l'aide de la lipase immobilisee
Soumanou et al. Crucial role of support and water activity on the lipase-catalyzed synthesis of structured triglycerides
JP2657887B2 (ja) 固定化酵素の調製方法
US6284501B1 (en) Interesterification of phospholipids
JP3509124B2 (ja) 固定化リパーゼを用いた油脂類のエステル交換方法
WO2003040091A2 (fr) Procede de dissociation de graisses
JP2676470B2 (ja) 固定化リパーゼ、その製造方法及び該リパーゼを用いた油脂類のエステル交換方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920131

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19941012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19950224